In order to deepen the reform of the system of evaluation, review and approval of drugs, promote studies on good clinical practice (GCP) on drugs and improve the quality of drugs, the National Medical Products Administration joined hands with the National Health Commission in revising the Good Clinical Practice on Drugs, which will take effect on 1 July 2020 to regulate the clinical trials of drugs for registration purposes. More
